Y. Shao

发表

Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment

Y. Shao, Xiaohua Ma, P. Paira, 2018, PloS one.

Pharmacological relationships and ligand discovery of G protein-coupled receptors revealed by simultaneous ligand and receptor clustering.

Cheng Zhang, Lin Tao, Peng Zhang, 2017, Journal of molecular graphics & modelling.

Structure‐Based Design and Synthesis of Highly Potent SARS‐CoV 3CL Protease Inhibitors

A. Yang, Y. Shao, Chi‐Huey Wong, 2007, Chembiochem : a European journal of chemical biology.

Screening for HIV protease inhibitors by protection against activity-mediated cytotoxicity in Escherichia coli.

Y. Shao, Chi‐Huey Wong, Yih-Shyun E. Cheng, 2006, Journal of virological methods.

Mutually co-operative interactions between modulators of P-glycoprotein.

Y. Shao, W. Stein, S. Ayesh, 1997, Biochimica et biophysica acta.

The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches

S. Moro, Y. Shao, G. Venkatesan, 2013, Medicinal research reviews.

Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein.

Y. Shao, W. Stein, S. Ayesh, 1996, Biochimica et biophysica acta.

Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease

A. Yang, Y. Shao, Chi‐Huey Wong, 2008, Bioorganic & Medicinal Chemistry.

The first pharmacophore model for potent NF-kappaB inhibitors.

Nai-Wan Hsiao, Y. Shao, K. Tsai, 2009, Bioorganic & medicinal chemistry letters.

Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonists.

Chun Wei Yap, Stephanie Federico, Giampiero Spalluto, 2011, Bioorganic & medicinal chemistry letters.